John McVey

John McVey is a distinguished expert in the fields of haemostasis and thrombosis, currently serving as Director and Chief Science Officer at PROFACTOR PHARMA LTD since 2022. In addition, John has been a Director and Consultant at Coagulare Biomedica Ltd since 2011, providing expertise in research, development, and bio-manufacturing. John held various academic roles, including Head of the Department of Biochemical Sciences and Professor of Cardiovascular Biology at the University of Surrey from 2013 to 2023. Additional visiting professorships were completed at Royal Holloway, University of London, University College London, and King's College London. Prior experience includes leadership positions at the Thrombosis Research Institute and the Medical Research Council, where John was pivotal in establishing an international reputation in the field. John McVey holds several prestigious qualifications, including FRSB and FRCPath, and earned a PhD in Biochemistry from the University of Glasgow.